dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution
- RxCUI
- 1234473
- RxNorm name
- dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution
- Display name
- Dextromethorphan/guaiFENesin (Oral Liquid)
- Full name
- dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution
- Term type
- SCD
- Status
- Active
- Strength
- 15-100 mg/5ml
- Dose form
- Sol
- Route
- Oral Liquid
- Updated
- 2026-07-17 22:19:59
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 012012
- Active start
- 012012
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| dextromethorphan hydrobromide | 3 MG / 1 ML | dextromethorphan | dextromethorphan hydrobromide |
| guaifenesin | 20 MG / 1 ML | guaifenesin | guaifenesin |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Solution | 316968 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| dextromethorphan | 3289 |
| guaifenesin | 5032 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | dextromethorphan hydrobromide 3 MG/ML / guaiFENesin 20 MG/ML Oral Solution | NAMES |
| RxNorm Name | dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution | NAMES |
| RxNorm Synonym | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG per 5 ML Oral Solution | NAMES |
| TTY | SCD | ATTRIBUTES |
| SPL_SET_ID | 0b638db4-5ed3-4665-abcd-f95e677adbd8 | CODES |
| SPL_SET_ID | 8aa32b2a-a8be-4f8d-9b1f-eb007bff8e65 | CODES |
| RxCUI | 1234473 | CODES |
| MMSL_CODE | BD4545 | CODES |
| MMSL_CODE | CD4545 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 49873-302-01 | 49873-302 | Stona Cough dextromethorphan hydrobromide, guaifenesin | Sato Pharmaceutical Co., Ltd. | M012 |
| 65131-091-08 | 65131-091 | BRONCOCHEM DEXTROMETHORPHAN HBr-GYAIFENESIN | LABORATORIO MAGNACHEM INTERNATIONAL SRL | part341 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| M012 | 49873-302 | Stona Cough dextromethorphan hydrobromide, guaifenesin | OTC MONOGRAPH DRUG | Sato Pharmaceutical Co., Ltd. |
| part341 | 65131-091 | BRONCOCHEM DEXTROMETHORPHAN HBr-GYAIFENESIN | OTC MONOGRAPH FINAL | LABORATORIO MAGNACHEM INTERNATIONAL SRL |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0b638db4-5ed3-4665-abcd-f95e677adbd8 | dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 4 | Stona Cough Syrup | 20231112 |
| 0b638db4-5ed3-4665-abcd-f95e677adbd8 | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 4 | Stona Cough Syrup | 20231112 |
| 0b638db4-5ed3-4665-abcd-f95e677adbd8 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Solution | PSN | 4 | Stona Cough Syrup | 20231112 |
| 3a7986cd-b16e-4201-95b1-f53b9a6c2529 | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 4 | Broncomar Maximum Cought Relief | 20160101 |
| 3a7986cd-b16e-4201-95b1-f53b9a6c2529 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Solution | PSN | 4 | Broncomar Maximum Cought Relief | 20160101 |
| 3a7986cd-b16e-4201-95b1-f53b9a6c2529 | dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 4 | Broncomar Maximum Cought Relief | 20160101 |
| 8aa32b2a-a8be-4f8d-9b1f-eb007bff8e65 | dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 3 | BRONCOCHEM MAXIMUM COUGH | 20161219 |
| 8aa32b2a-a8be-4f8d-9b1f-eb007bff8e65 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Solution | PSN | 3 | BRONCOCHEM MAXIMUM COUGH | 20161219 |
| 8aa32b2a-a8be-4f8d-9b1f-eb007bff8e65 | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 3 | BRONCOCHEM MAXIMUM COUGH | 20161219 |
| afbee087-62dc-4f5d-8155-2d6c1de320ed | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Solution | PSN | 1 | 20140612 | |
| afbee087-62dc-4f5d-8155-2d6c1de320ed | dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 1 | 20140612 | |
| afbee087-62dc-4f5d-8155-2d6c1de320ed | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 1 | 20140612 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 0b638db4-5ed3-4665-abcd-f95e677adbd8 | Stona Cough Syrup | Sato Pharmaceutical Co., Ltd. | 20231112 |
| 8aa32b2a-a8be-4f8d-9b1f-eb007bff8e65 | BRONCOCHEM MAXIMUM COUGH | LABORATORIO MAGNACHEM INTERNATIONAL SRL | 20161219 |
| 3a7986cd-b16e-4201-95b1-f53b9a6c2529 | Broncomar Maximum Cought Relief | Dannso Corp./d.b.a. Essential Products | All Pharma LLC | 20160101 |
| afbee087-62dc-4f5d-8155-2d6c1de320ed | Gadal Laboratories Inc | 20140612 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R05CA | Expectorants | ATC1-4 | guaifenesin | |
| ATC | R05DA | Opium alkaloids and derivatives | ATC1-4 | dextromethorphan | |
| FDASPL | N0000193956 | Expectorant | EPC | has_epc | guaifenesin |
| FDASPL | N0000182149 | Sigma-1 Agonist | EPC | has_epc | dextromethorphan |
| FDASPL | N0000181821 | Uncompetitive N-methyl-D-aspartate Receptor Antagonist | EPC | has_epc | dextromethorphan |
| FDASPL | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan |
| FDASPL | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan |
| MEDRT | D003915 | Dextromethorphan | CHEM | has_ingredient | dextromethorphan hydrobromide |
| MEDRT | D003915 | Dextromethorphan | CHEM | has_ingredient | dextromethorphan |
| MEDRT | D006140 | Guaifenesin | CHEM | has_ingredient | guaifenesin |
| MEDRT | D001991 | Bronchitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_prevent | dextromethorphan |
| MEDRT | D003371 | Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dextromethorphan hydrobromide |
| MEDRT | D003371 | Cough | DISEASE | may_prevent | dextromethorphan hydrobromide |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dextromethorphan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dextromethorphan hydrobromide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dextromethorphan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | guaifenesin |
| MEDRT | D007827 | Laryngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D010612 | Pharyngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | guaifenesin |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D014917 | Whooping Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | dextromethorphan |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | dextromethorphan hydrobromide |
| MEDRT | N0000000109 | Serotonin Uptake Inhibitors | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000000109 | Serotonin Uptake Inhibitors | MOA | has_moa | dextromethorphan |
| MEDRT | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan |
| MEDRT | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan |
| MEDRT | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | dextromethorphan |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | dextromethorphan hydrobromide |
| MEDRT | N0000008867 | Decreased Respiratory Secretion Viscosity | PE | has_pe | guaifenesin |
| MEDRT | N0000009560 | Increased Respiratory Secretions | PE | has_pe | guaifenesin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 3 MG/ML / 20 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | SCD |
| CODES | MMSL_CODE | BD4545 |
| CODES | MMSL_CODE | CD4545 |
| CODES | RxCUI | 1234473 |
| CODES | SPL_SET_ID | 0b638db4-5ed3-4665-abcd-f95e677adbd8 |
| CODES | SPL_SET_ID | 8aa32b2a-a8be-4f8d-9b1f-eb007bff8e65 |
| CODES | VUID | 4005457 |
| CODES | VUID | 4005458 |
| CODES | VUID | 4005469 |
| NAMES | Prescribable Synonym | dextromethorphan HBr 30 MG / guaiFENesin 200 MG in 10 mL Oral Solution |
| NAMES | RXNAV_STR | dextromethorphan hydrobromide 3 MG/ML / guaiFENesin 20 MG/ML Oral Solution |
| NAMES | RxNorm Name | dextromethorphan hydrobromide 3 MG/ML / guaifenesin 20 MG/ML Oral Solution |
| NAMES | RxNorm Synonym | dextromethorphan hydrobromide 15 MG / guaifenesin 100 MG per 5 ML Oral Solution |
| NAMES | Tallman Synonym | dextromethorphan hydrobromide 15 MG / guaiFENesin 100 MG per 5 ML Oral Solution |
| NAMES | Tallman Synonym | dextromethorphan hydrobromide 3 MG/ML / guaiFENesin 20 MG/ML Oral Solution |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |